Search PubMed⌕ Search

Biomedical subjects

K Sunakawa

Publications and source records attributed to K Sunakawa.

132 records · Page 8Linked to original sources

A morphological study in germfree mice (Salmonella infection).

The morphological manifestation of the intestinal infections of Salmonella typhimurium by the intestine rolled method in both conventional DKI and germfree mice have been investigated in our laboratory. In the conventional mice, the morphological manifestation of intestinal infection shows no difference from the general features of infection, while in the germfree mice, the manifestation is characterized by the so-called non-reactive necrotizing enteritis without cellular reaction. When infection in the germfree mice occurs, some state of immunological insufficiency should be taken into consideration. In infections of germfree mice it is difficult to consider the immunological or the allergic reaction which is expected in the conventional mice. In addition, the direct influences of bacteria such as endotoxin must be taken into consideration as another possibility, but the very limited localized lesions, as seen in this experiment cannot always be suggested to be due to the direct influence of bacteria or intoxication. Though there are many problems to be solved in the future, we are now able to state a kind of mechanism similar to that of Shwartzman's phenomenon cannot be ignored in the infection in newborns or in immunologically immature animals.

Animals↗

[Basic and clinical examinations of CS-1170 in pediatrics (author's transl)].

1. CS-1170 was administered for the purpose of prophylaxis during cardiac catheterization in patients with heart disease, and its blood levels were measured. 2. The mean blood level (Moni-Trol I standard) after one intravenous shot of 20 mg/kg was 53.6 mcg/ml in catheterized children aged below 6 and 66.9 mcg/ml in catheterized children aged above 10 at 30 minutes, and 1.95 mcg/ml and 5.2 mcg/ml respectively at 6 hours. 3. The mean half life of the blood level was 1.09 hours in catheterized children aged below 6, 1.37 hours in catheterized children aged above 10, and 0.71 hours in infections children. 4. The urinary excretion seemed satisfactorily high although there was a great variation. 5. The clinical efficacy was 88.9%. 6. The bacteriological efficacy was 100% for E. coli, Klebsiella, Proteus mirabilis and Staphylococcus aureus and was 0% for Staphylococcus epidermidis. 7. Although GOT and GPT were elevated in one case as a side effect, they rapidly returned to normal after discontinuation of administration.

Adolescent↗

[Fundamental and clinical studies of PC-904 in pediatrics (author's transl)].

The following studies were carried out in pediatric patients. 1. Serum levels of PC-904 were examined in 3 patients by 1 hour intravenous infusion of 20 mg/kg, reaching the peak of 22.5 approximately 25.5 microgram/ml at the end of infusion. Half life was 37 approximately 48 minutes. 2. Investigated in only 1 patient, the urinary excretion rate was 12.9% (0 approximately 6 hours). 3. The effect of PC-904 on blood pressure was examined in 1 patient, and no effect was observed. 4. Clinical effects of PC-904 were examined in 9 patients; urinary tract infection (6 cases) and Salmonella enteritis (3 cases). The daily dose was 32.6 approximately 93.0 mg/kg. The overall clinical effectiveness was 66.7%. As to causative organisms E. coli, Klebsiella and Salmonella were isolated. The clinical effects by the organisms were 100%, 0%, and 66.7%, respectively. 5. Slight elevation of GOT and GPT and eosinophilia were observed in each one case but these abnormalities rapidly returned to pre-treatment levels when the administration was discontinued. No other side effects were noticed.

Adolescent↗